Type: Pancreatic cancer

A/Prof Griffin will conduct pre-clinical tests of a much needed new combination treatment for patients with advanced pancreatic and bowel cancers.

Researchers will use cutting-edge imaging technology and lab models that mimic pancreatic cancer and watch tumour response to treatment.

Researchers will test a dual treatment approach that targets collagen production in pancreatic cancer tumours.

This project aims to improve treatment by monitoring an individual’s response to immunotherapy. 

This innovative research could be a breakthrough in treating pancreatic cancer and improving survival outcomes.

Associate Professor Phoebe Phillips and her team have come up with a new way to target the cells that help the spread of aggressive pancreatic cancer.

This project aims to develop a way to increase the effectiveness of chemotherapy in pancreatic cancer using a dual treatment approach that targets the production of protective tissue in the tumour.

This project aims to develop a tailored treatment approach for pancreatic cancer, providing more effective options and boosting the chances of a good outcome.

Professor John Rasko

If this treatment is shown to be effective, it will provide much-needed hope for patients who receive the devastating diagnosis of pancreatic cancer.

This project will determine how drug resistance develops at the genetic level and explore ways of making treatment approaches more effective.